Seven years of experience with the centrifugal pump in patients with cardiogenic shock.
From September 1987 to September 1994 61 patients between 29 and 78 years of age received mechanical circulatory support by means of the Biomedicus centrifugal pump. The patients were divided into three groups by indication: Group I included 15 patients with early postcardiotomy cardiogenic shock and 24 patients with late postcardiotomy cardiogenic shock. Group II 11 patients with therapy-resistant cardiogenic shock following acute myocardial infarction, and Group III 11 patients with cardiogenic shock of other etiologies. Duration of support was 1 to 347 hours. Survival rates were 46.7% and 33.3% in patients with early and late postcardiotomy cardiogenic shock, respectively (Group I), 27.2% in Group II, and 18.1% in Group III. Most frequent complications were bleeding (40%, 58%) and acute renal failure (26.7%, 29.2%) in Group I and multiple organ failure in Groups II and III (64% and 45.5%). Major causes of death were bleeding and multiple organ failure in Group I (37.5%) and multiple organ failure in Groups II and III (87.5% and 50%). Groups II and III (87.5% and 50%).
El-Banayosy
A
A
Department of Thoracic and Cardiovascular Surgery, University of Bochum, Bad Oeynhausen, Germany. Bad Oeynhausen, Germany.
Posival
H
H
Minami
K
K
Kizner
L
L
Breymann
T
T
Seifert
D
D
Arusoglu
L
L
Körner
M M
MM
Döring
B
B
Hartmann
D
D
D000328:Adult; D000368:Aged; D003327:Coronary Disease / Q000601:surgery; D005260:Female; D006331:Heart Diseases / Q000601:surgery; D006353:Heart-Assist Devices; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000628:therapy*; D012189:Retrospective Studies; D012770:Shock, Cardiogenic / Q000097:blood / Q000209:etiology / Q000628:therapy*; D016896:Treatment Outcome